| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 2793 |
| 1 | METHOTREXATE | 1647 |
| 2 | ETANERCEPT | 1323 |
| 3 | ADALIMUMAB | 1282 |
| 4 | TOFACITINIB | 1041 |
| 5 | PREDNISONE | 891 |
| 6 | LEFLUNOMIDE | 878 |
| 7 | ABATACEPT | 723 |
| 8 | SULFASALAZINE | 700 |
| 9 | TOCILIZUMAB | 684 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONASEMNOGENE ABEPARVOVEC-XIOI | 92 | 0.0685 |
| 1 | TAGRAXOFUSP | 16 | 0.0648 |
| 2 | INDOCYANINE GREEN | 5 | 0.0617 |
| 3 | AZATHIOPRINE SODIUM | 56 | 0.0516 |
| 4 | PEXIDARTINIB | 26 | 0.0506 |
| 5 | REMDESIVIR | 410 | 0.0444 |
| 6 | SOTORASIB | 23 | 0.0343 |
| 7 | CHOLIC ACID | 8 | 0.0335 |
| 8 | GOLD | 110 | 0.0277 |
| 9 | RIFAPENTINE | 8 | 0.0224 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1646 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 1634 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 1623 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 980 |
| 4 | Antirheumatic Agent [EPC] | 878 |
| 5 | Kinase Inhibitor [EPC] | 802 |
| 6 | Aminosalicylate [EPC] | 737 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 723 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 714 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 611 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 16 | 0.0648 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 410 | 0.0444 |
| 2 | Interferon gamma Blocker [EPC] | 1 | 0.0179 |
| 3 | Aldehyde Dehydrogenase Inhibitor [EPC] | 13 | 0.0169 |
| 4 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0154 |
| 5 | Interleukin-6 Antagonist [EPC] | 4 | 0.0136 |
| 6 | Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC] | 6 | 0.0128 |
| 7 | Inactivated Influenza B Virus Vaccine [EPC] | 1 | 0.0127 |
| 8 | Leptin Analog [EPC] | 9 | 0.0109 |
| 9 | Lipid Emulsion [EPC] | 18 | 0.0106 |